Recombinant Human Endostatin Market 2027 By Application | The Insight Partners

Recombinant Human Endostatin Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Application (Medical Application, Scientific Application)

Report Code: TIPRE00011087 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Endostatin is a protein that is located in most Basement Membranes (BMs) in the body, such as vascular basement membranes. Some clinical studies have validated the significant survival benefits of recombinant human endostatin in treating late-stage Non-Small-Cell Lung Carcinoma (NSCLC).

MARKET DYNAMICS

The recombinant human endostatin market is driving due to government initiatives to reduce prices of anticancer drugs. However, increasing challenges in significant production of recombinant human endostatin is expected to hinder the market growth. Moreover, increasing research and development activities for identifying potential uses of recombinant human endostatin is expected to propel growth of the market.

MARKET SCOPE

The "Recombinant Human Endostatin Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of recombinant human endostatin market with detailed market segmentation by application. The recombinant human endostatin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in recombinant human endostatin market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The recombinant human endostatin market is segmented on the basis of application. On the basis of application, the market is categorized as medical application and scientific application.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the recombinant human endostatin market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant human endostatin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting recombinant human endostatin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the recombinant human endostatin market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the recombinant human endostatin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from recombinant human endostatin market are anticipated to have lucrative growth opportunities in the future with the rising demand for recombinant human endostatin in the global market. Below mentioned is the list of few companies engaged in the recombinant human endostatin market.

The report also includes the profiles of key players in recombinant human endostatin market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Biocon
  •   FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.
  •   Genexine, Inc.
  •   Hetero
  •   Novus Biologicals
  •   Onyx Pharmaceuticals, Inc.,
  •   PeproTech, Inc.
  •   Pfizer Inc.
  •   Thermo Fisher Scientific
  •   Yantai Medgenn Ltd.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Human Endostatin Market - By Application
1.3.2 Recombinant Human Endostatin Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT HUMAN ENDOSTATIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT HUMAN ENDOSTATIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RECOMBINANT HUMAN ENDOSTATIN MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT HUMAN ENDOSTATIN - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT HUMAN ENDOSTATIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT HUMAN ENDOSTATIN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. MEDICAL APPLICATION
7.3.1. Overview
7.3.2. Medical Application Market Forecast and Analysis
7.4. SCIENTIFIC APPLICATION
7.4.1. Overview
7.4.2. Scientific Application Market Forecast and Analysis
8. RECOMBINANT HUMAN ENDOSTATIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Recombinant Human Endostatin Market Overview
8.1.2 North America Recombinant Human Endostatin Market Forecasts and Analysis
8.1.3 North America Recombinant Human Endostatin Market Forecasts and Analysis - By Application
8.1.4 North America Recombinant Human Endostatin Market Forecasts and Analysis - By Countries
8.1.4.1 United States Recombinant Human Endostatin Market
8.1.4.1.1 United States Recombinant Human Endostatin Market by Application
8.1.4.2 Canada Recombinant Human Endostatin Market
8.1.4.2.1 Canada Recombinant Human Endostatin Market by Application
8.1.4.3 Mexico Recombinant Human Endostatin Market
8.1.4.3.1 Mexico Recombinant Human Endostatin Market by Application
8.2. EUROPE
8.2.1 Europe Recombinant Human Endostatin Market Overview
8.2.2 Europe Recombinant Human Endostatin Market Forecasts and Analysis
8.2.3 Europe Recombinant Human Endostatin Market Forecasts and Analysis - By Application
8.2.4 Europe Recombinant Human Endostatin Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Recombinant Human Endostatin Market
8.2.4.1.1 Germany Recombinant Human Endostatin Market by Application
8.2.4.2 France Recombinant Human Endostatin Market
8.2.4.2.1 France Recombinant Human Endostatin Market by Application
8.2.4.3 Italy Recombinant Human Endostatin Market
8.2.4.3.1 Italy Recombinant Human Endostatin Market by Application
8.2.4.4 Spain Recombinant Human Endostatin Market
8.2.4.4.1 Spain Recombinant Human Endostatin Market by Application
8.2.4.5 United Kingdom Recombinant Human Endostatin Market
8.2.4.5.1 United Kingdom Recombinant Human Endostatin Market by Application
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Recombinant Human Endostatin Market Overview
8.3.2 Asia-Pacific Recombinant Human Endostatin Market Forecasts and Analysis
8.3.3 Asia-Pacific Recombinant Human Endostatin Market Forecasts and Analysis - By Application
8.3.4 Asia-Pacific Recombinant Human Endostatin Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Recombinant Human Endostatin Market
8.3.4.1.1 Australia Recombinant Human Endostatin Market by Application
8.3.4.2 China Recombinant Human Endostatin Market
8.3.4.2.1 China Recombinant Human Endostatin Market by Application
8.3.4.3 India Recombinant Human Endostatin Market
8.3.4.3.1 India Recombinant Human Endostatin Market by Application
8.3.4.4 Japan Recombinant Human Endostatin Market
8.3.4.4.1 Japan Recombinant Human Endostatin Market by Application
8.3.4.5 South Korea Recombinant Human Endostatin Market
8.3.4.5.1 South Korea Recombinant Human Endostatin Market by Application
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Recombinant Human Endostatin Market Overview
8.4.2 Middle East and Africa Recombinant Human Endostatin Market Forecasts and Analysis
8.4.3 Middle East and Africa Recombinant Human Endostatin Market Forecasts and Analysis - By Application
8.4.4 Middle East and Africa Recombinant Human Endostatin Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Recombinant Human Endostatin Market
8.4.4.1.1 South Africa Recombinant Human Endostatin Market by Application
8.4.4.2 Saudi Arabia Recombinant Human Endostatin Market
8.4.4.2.1 Saudi Arabia Recombinant Human Endostatin Market by Application
8.4.4.3 U.A.E Recombinant Human Endostatin Market
8.4.4.3.1 U.A.E Recombinant Human Endostatin Market by Application
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Recombinant Human Endostatin Market Overview
8.5.2 South and Central America Recombinant Human Endostatin Market Forecasts and Analysis
8.5.3 South and Central America Recombinant Human Endostatin Market Forecasts and Analysis - By Application
8.5.4 South and Central America Recombinant Human Endostatin Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Recombinant Human Endostatin Market
8.5.4.1.1 Brazil Recombinant Human Endostatin Market by Application
8.5.4.2 Argentina Recombinant Human Endostatin Market
8.5.4.2.1 Argentina Recombinant Human Endostatin Market by Application
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RECOMBINANT HUMAN ENDOSTATIN MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. RECOMBINANT HUMAN ENDOSTATIN MARKET, KEY COMPANY PROFILES
11.1. BIOCON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. FUJIFILM KYOWA KIRIN BIOLOGICS CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GENEXINE, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. HETERO
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVUS BIOLOGICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ONYX PHARMACEUTICALS, INC.,
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PEPROTECH, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. THERMO FISHER SCIENTIFIC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. YANTAI MEDGENN LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Biocon
2. FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.
3. Genexine, Inc.
4. Hetero
5. Novus Biologicals
6. Onyx Pharmaceuticals, Inc.,
7. PeproTech, Inc.
8. Pfizer Inc.
9. Thermo Fisher Scientific
10. Yantai Medgenn Ltd.
TIPRE00011087
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking